Ledger.Open graph →
SEC Form D · Amendment · filed January 16, 2018

ENDOSTIM, INC

Offering
$25.0M
Sold
$12.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
Dallas, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Alexander S. Schmitz · Dallas, TXDirectorRohan J. Hoare · Dallas, TXExec · DirectorKimberly S. Pinson · Dallas, TXExecVirender K. Sharma · Dallas, TXExecPaul K. Goode · Dallas, TXExecDouglas D. French · Dallas, TXDirectorJon Pelzer · Palm Beach, FLExecFrederic Meriot · NEW YORK, NYDirectorDonald A. Direnzo, Jr · Jericho, NYExec · DirectorJanet Gervasio · NEW YORK, NYExecAlex Diaz-Asper · Palm Beach, FLExecMary Ann W. Todd · Chicago, ILExec · DirectorMark Srulowitz · New York, NYExecJaspreet Dehl · New York, NYDirectorKeiji Hattori · New York, NYExecRon Bloom · New York, NYExecDouglas D. French · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗